Any one of these cutting-edge areas of research would have a billion dollar value for a pharma, if an outcome was a blockbuster drug.
Over the years they have highlighted Amgen's 2007 acquistion of Avidia for US$380m.
Four years on from Avidia's sale,I'm happy to work with >400mill.
ST
pre final report, page-14
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $410.3K | 2.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 521349 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 474233 | 11 |
View Market Depth
| Last trade - 12.56pm 30/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |